Keyphrases
Cancer Therapy
100%
Colorectal Cancer
100%
Neoadjuvant
100%
Short-course Radiation Therapy
100%
Total Neoadjuvant Therapy
100%
Short Course
90%
Chemoradiation
60%
Progression-free Survival
30%
Treatment Completion
20%
Complete Response
20%
Locally Advanced Rectal Cancer
20%
Neoadjuvant Rectal Score
20%
Retrospective Cohort Study
10%
United States
10%
Europe
10%
Disease Severity
10%
Chemotherapy
10%
Cancer Center
10%
National Cancer Institute
10%
Performance Outcomes
10%
Consolidation Chemotherapy
10%
Local Control
10%
Recurrence Rate
10%
Neoadjuvant Therapy
10%
Oncological Outcomes
10%
Local Recurrence
10%
Treatment Modalities
10%
Australia
10%
Combined Modality Therapy
10%
Clinical Performance
10%
High Burden
10%
Downstaging
10%
Tumor Downstaging
10%
Treatment Characteristics
10%
Node-positive Disease
10%
Fluorouracil
10%
Retrospective Design
10%
Preservation Rate
10%
Optimal Regimen
10%
Disease Variables
10%
Diverting Ostomy
10%
Oxaliplatin-based Chemotherapy
10%
Temporary Stoma
10%
Sphincter Preservation
10%
Medicine and Dentistry
Cancer Therapy
100%
Neoadjuvant Therapy
100%
Rectum Cancer
100%
Chemoradiotherapy
54%
Progression Free Survival
27%
Malignant Neoplasm
18%
Neoplasm
9%
Disease Severity
9%
Retrospective Cohort Study
9%
Recurrent Disease
9%
Consolidation Chemotherapy
9%
Recurrence Risk
9%
Oxaliplatin
9%
Fluorouracil
9%
Ostomy
9%
Stoma
9%
Diseases
9%
Sphincter
9%
Nursing and Health Professions
Neoadjuvant Therapy
100%
Cancer Therapy
100%
Rectum Cancer
100%
Chemoradiotherapy
54%
Progression Free Survival
27%
Neoplasm
9%
Disease Severity
9%
Cohort Analysis
9%
Recurrent Disease
9%
National Health Organization
9%
Recurrence Risk
9%
Cancer Center
9%
Fluorouracil
9%
Consolidation Chemotherapy
9%
Oxaliplatin
9%
Ostomy
9%
Diseases
9%
Pharmacology, Toxicology and Pharmaceutical Science
Chemoradiation Therapy
100%
Rectum Cancer
100%
Progression Free Survival
50%
Chemotherapy
50%
Malignant Neoplasm
33%
Cohort Study
16%
Neoplasm
16%
Recurrent Disease
16%
Disease Severity
16%
Oxaliplatin
16%
Recurrence Risk
16%
Fluorouracil
16%
Diseases
16%